We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+16.8%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$2.63B
AUM Growth
+$690M
Cap. Flow
+$451M
Cap. Flow %
17.16%
Top 10 Hldgs %
21.75%
Holding
1,066
New
264
Increased
497
Reduced
181
Closed
122

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$21.1M
2
MTCH icon
Match Group
MTCH
+$16.7M
3
AMZN icon
Amazon
AMZN
+$15.3M
4
MELI icon
Mercado Libre
MELI
+$13.9M
5
PDD icon
Pinduoduo
PDD
+$13.6M

Top Sells

Rank Stock Value
1
BBBY
Bed Bath & Beyond
BBBY
+$16M
2
PPLI
People Inc
PPLI
+$7.82M
3
ZM icon
Zoom
ZM
+$7.6M
4
KLAC icon
KLA
KLAC
+$7.1M
5
WUBA
58.com Inc
WUBA
+$6.96M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 35.11%
2 Technology 20.8%
3 Communication Services 14.79%
4 Industrials 4.05%
5 Financials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRWD icon
801
Ironwood Pharmaceuticals
IRWD
$714M
$12K ﹤0.01%
+1,366
New +$13.6K
MOH icon
802
Molina Healthcare
MOH
$10.3B
$12K ﹤0.01%
68
+8
+13% +$1.46K
WRB icon
803
W.R. Berkley
WRB
$26.6B
$12K ﹤0.01%
459
+54
+13% +$1.48K
CGEN icon
804
Compugen
CGEN
$228M
$11K ﹤0.01%
+706
New +$11.6K
CHRS icon
805
Coherus Oncology
CHRS
$196M
$11K ﹤0.01%
+610
New +$11.3K
MGNX icon
806
MacroGenics
MGNX
$257M
$11K ﹤0.01%
+464
New +$12.7K
OHI icon
807
Omega Healthcare
OHI
$14.7B
$11K ﹤0.01%
374
+44
+13% +$1.37K
SGMO
808
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$11K ﹤0.01%
+1,204
New +$13K
ICPT
809
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$11K ﹤0.01%
+282
New +$13K
DRNA
810
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$11K ﹤0.01%
+638
New +$13.2K
VER
811
DELISTED
VEREIT, Inc.
VER
$11K ﹤0.01%
360
+42
+13% +$1.38K
LNC icon
812
Lincoln National
LNC
$8.81B
$10K ﹤0.01%
340
-34,903
-99% -$1.25M
NTLA icon
813
Intellia Therapeutics
NTLA
$1.67B
$10K ﹤0.01%
+504
New +$10.5K
RCKT icon
814
Rocket Pharmaceuticals
RCKT
$394M
$10K ﹤0.01%
+472
New +$11.6K
REG icon
815
Regency Centers
REG
$14.1B
$10K ﹤0.01%
272
+32
+13% +$1.31K
UHS icon
816
Universal Health Services
UHS
$10.5B
$10K ﹤0.01%
102
+12
+13% +$1.28K
EPZM
817
DELISTED
Epizyme, Inc
EPZM
$10K ﹤0.01%
+866
New +$11.6K
LMNX
818
DELISTED
Luminex Corp
LMNX
$10K ﹤0.01%
+398
New +$12.2K
AKRO
819
DELISTED
Akero Therapeutics
AKRO
$9K ﹤0.01%
+298
New +$10.4K
CMA
820
DELISTED
Comerica
CMA
$9K ﹤0.01%
238
-22,239
-99% -$855K
INVA icon
821
Innoviva
INVA
$1.48B
$9K ﹤0.01%
+864
New +$11K
KPTI icon
822
Karyopharm Therapeutics
KPTI
$48M
$9K ﹤0.01%
+42
New +$10.3K
QTRX icon
823
Quanterix
QTRX
$190M
$9K ﹤0.01%
+268
New +$8.63K
RGA icon
824
Reinsurance Group of America
RGA
$16.1B
$9K ﹤0.01%
102
+12
+13% +$1.08K
STOK icon
825
Stoke Therapeutics
STOK
$2.11B
$9K ﹤0.01%
+286
New +$8.17K
31 32
33
34 35

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Penserra Capital Management held 1,066 positions worth $2.63B, up 36% from $1.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Penserra Capital Management deployed $451M of net new capital in Q3 2020, opening 264 new positions and adding to 497 existing holdings. Its largest new stake was Match Group: 157,606 shares worth $17.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Bed Bath & Beyond, an estimated $16M trimmed.

  • Penserra Capital Management's largest Q3 2020 buy was Match Group: 157,606 shares worth $17.4M.
  • Penserra Capital Management added most to Alibaba in Q3 2020, an estimated $21.1M increase.
  • Penserra Capital Management's biggest Q3 2020 reduction was Bed Bath & Beyond, cutting an estimated $16M.
  • Penserra Capital Management fully exited 58.com Inc in Q3 2020, selling an estimated $6.96M.
  • Penserra Capital Management's ten largest holdings make up 22% of its $2.63B portfolio in Q3 2020.
  • Penserra Capital Management opened 264 new positions and closed 122 in Q3 2020.
  • Penserra Capital Management's portfolio value rose 36% quarter-over-quarter to $2.63B.

Based on Penserra Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.